08045804815

TABNCAP HEALTHCARE
GST : 24AAMFT3098D1Z1

Our Products

Ophthalmic Diagnostic Test Strips

Intraocular Lenses

Contact Lenses

Ophthalmic Solutions and Viscoelastics

Vitreoretinal Products

Ophthalmic Machine

Hyaluronic Acid Gel for Dremel

Hyaluronic Acid Gel for Dremel

Absorbable Hemostatic Gelatin Sponge And Powder

Natural Colors Contact Lens

Home Care Products

Skin Care Products

Rapacan 1mg Tablets

Rapacan 1mg Tablets Specification

Function
Immunosuppression, prevention of kidney transplant rejection

Storage Instructions
Store below 25C, protect from moisture and light

Measurement Range
1mg per tablet

Usage Type
Prescription

Features
Once-daily dosage, film-coated tablet, immunosuppressive properties

Frequency
As prescribed (typically once daily)

Instruments Type
Tablet

Accuracy
Pharmaceutical-grade formulation

Shelf Life
24 months

Equipment Type
Pharmaceutical Tablet

Material
Active: Sirolimus; Excipients: Tablet base

Condition
New

Technology
Immunosuppressant Drug Formulation

Portable
Yes

Wall Mounted
No

Operating Type
Oral Administration

Use
Prevention of organ rejection in renal transplant patients

Color
White

Packaging Size
10 tablets per strip

Brand Name
Rapacan

Active Ingredient
Sirolimus 1mg

Prescription Required
Yes

Drug Class
Immunosuppressant

Administration Route
Oral

Packaging Type
Blister strip in carton box

Indications
Prophylaxis of organ rejection in renal transplantation

Rapacan 1mg Tablets Trade Information

Minimum Order Quantity
100 Packs

FOB Port
AHMEDABAD

Payment Terms
Paypal, Cash Advance (CA), Cash in Advance (CID), Letter of Credit at Sight (Sight L/C), Letter of Credit (L/C)

Delivery Time
3 Days

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
Box

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

About Rapacan 1mg Tablets

Rapacan 1mg Tablets contain Sirolimus, an immunosuppressive drug used to prevent organ rejection in transplant patients. It is commonly prescribed after kidney, liver, or heart transplants. Sirolimus works by inhibiting the activation and proliferation of T cells, which are involved in the immune response that can lead to transplant rejection.

Key Uses:

Organ Transplantation: After a kidney transplant, Rapacan 1mg helps prevent organ rejection by suppressing the immune system.
Autoimmune Conditions: In some cases, it may be used for other autoimmune conditions or certain types of cancers.

Mechanism of Action:

Sirolimus blocks the action of a protein called mTOR (mechanistic target of rapamycin), which is essential for cell growth, proliferation, and survival. By inhibiting mTOR, Rapacan reduces the ability of immune cells to divide and attack the transplanted organ.

Common Side Effects:

Increased risk of infections due to immune suppression.
Nausea, vomiting, or diarrhea.
High blood pressure and elevated cholesterol levels.
Liver problems and kidney issues may occur, requiring monitoring.

Dosage:

The dosage of Rapacan 1mg is individualized based on the patient's condition and response to treatment. Regular blood tests are necessary to monitor the drug's effectiveness and avoid toxicity.

Patients taking Rapacan should follow their healthcare providers instructions closely and attend scheduled follow-up appointments for monitoring.

Reliable Immunosuppressive Therapy for Transplant Patients

Rapacan 1mg Tablets are formulated with Sirolimus, an established immunosuppressant trusted in the management of post-renal transplantation care. These tablets help prevent organ rejection, enabling recipients to maintain optimal kidney function. Backed by clinical expertise, Rapacan is manufactured in India and adheres to rigorous quality standards, delivering consistent therapeutic benefits to patients worldwide.

Easy and Convenient Daily Dosage

With a once-daily administration, Rapacan 1mg Tablets simplify the routine for transplant patients. The film-coated, oral tablets offer ease of use and comfort, enhancing adherence to medication schedules. Packaged in practical blister strips, they are portable and suitable for home or travel, ensuring patients can maintain therapy without disruption.

FAQ's of Rapacan 1mg Tablets:

Q: How should Rapacan 1mg Tablets be taken for optimal effectiveness?

A: Rapacan 1mg Tablets are designed for oral administration, usually once daily or as directed by a healthcare professional. It is important to take the tablet with water, preferably at the same time each day, to maintain consistent blood levels and maximize protection against organ rejection.

Q: What is the primary benefit of using Rapacan 1mg Tablets after renal transplantation?

A: The main advantage of Rapacan 1mg Tablets is their ability to reduce the risk of kidney transplant rejection. The active ingredient, Sirolimus, works by suppressing the immune system, helping the body to accept the transplanted organ and improving the chances of long-term success.

Q: When should Rapacan 1mg Tablets be started following a kidney transplant?

A: Rapacan 1mg Tablets are typically initiated shortly after the renal transplant procedure, as prescribed by your transplant specialist. The exact timing and dosage depend on individual patient needs and should only be determined by your healthcare provider.

Q: Where should Rapacan 1mg Tablets be stored to maintain their quality?

A: To preserve their effectiveness, Rapacan 1mg Tablets should be stored in their original blister strips below 25C, protected from moisture and light. Ensuring correct storage extends their shelf life and prevents degradation of the active ingredient.

Q: What is the process for obtaining Rapacan 1mg Tablets?

A: Rapacan 1mg Tablets require a healthcare professional's prescription. Once prescribed, they can be obtained from authorized pharmacies, suppliers, or wholesalers. Always follow the guidance provided by your doctor and pharmacist when acquiring and using this medication.

Q: How do the immunosuppressive properties of Rapacan 1mg Tablets aid in transplant medicine?

A: Sirolimus, the active ingredient, selectively inhibits immune responses that can lead to rejection of a transplanted kidney. By moderating this immune activity, Rapacan 1mg Tablets support the body's adaptation to the new organ while minimizing complications.

Tell us about your requirement